- Title
- Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis
- Creators
- Sabrina Paganoni - Clinical Research InstituteEric A. Macklin - Harvard UniversitySuzanne Hendrix - TetraLogic Pharmaceuticals (United States)James D. Berry - Massachusetts General HospitalMichael A. Elliott - Neuroscience InstituteSamuel Maiser - Hennepin Healthcare Research InstituteChafic Karam - Oregon Health & Science UniversityJames B. Caress - Wake Forest UniversityMargaret A. Owegi - Memorial Medical CenterAdam Quick - The Ohio State UniversityJeremy M. Shefner - Barrow Neurological Instituteet al.
- Publication Details
- The New England journal of medicine, Vol.383(10), pp.919-930
- Number of pages
- 12
- Grant note
- Amyotrophic Lateral Sclerosis Association (100000971) Amylyx Pharmaceuticals S10OD020007 / NIH Office of the Director (http://data.elsevier.com/vocabulary/SciValFunders/100000052) NIH Office of the Director (http://data.elsevier.com/vocabulary/SciValFunders/100000052) Amyotrophic Lateral Sclerosis Association (http://data.elsevier.com/vocabulary/SciValFunders/100000971) Amylin Pharmaceuticals (http://data.elsevier.com/vocabulary/SciValFunders/100004323) ALS Finding a Cure Foundation
- Identifiers
- 991006262155202656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis
The New England journal of medicine, Vol.383(10), pp.919-930
09/03/2020
PMID: 32877582
Metrics
1 Record Views